Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05474573
What this trial is testing

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

Who this might be right for
Glioma, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 52
Not applicableActive Not RecruitingNCT04634617
What this trial is testing

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Who this might be right for
Endometrial CarcinomaMalignant Uterine NeoplasmUterine Corpus Cancer+1 more
M.D. Anderson Cancer Center 310
Not applicableStudy completedNCT02778191
What this trial is testing

Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Medical Center Groningen 413
Testing effectiveness (Phase 2)UnknownNCT05024318
What this trial is testing

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Ended earlyNCT05583110
What this trial is testing

Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma
Spanish Breast Cancer Research Group 13
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Not applicableStudy completedNCT05902260
What this trial is testing

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Joachim Aerts, MD PhD 51
Testing effectiveness (Phase 2)Looking for participantsNCT07269782
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 60
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT00200382
What this trial is testing

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Rasim Gucalp 27
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)UnknownNCT01872962
What this trial is testing

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 480
Not applicableStudy completedNCT06257888
What this trial is testing

A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients

Who this might be right for
Breast Neoplasm Malignant Primary
Renato Cagnacci Neto 90
Testing effectiveness (Phase 2)WithdrawnNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami
Early research (Phase 1)Looking for participantsNCT07054346
What this trial is testing

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Who this might be right for
Prostate CancerProstate Cancer (Diagnosis)High-risk Prostate Cancer+2 more
Thomas Hope 45
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Not applicableUnknownNCT00899613
What this trial is testing

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
University Hospital, Caen 270
Large-scale testing (Phase 3)Ended earlyNCT04746924
What this trial is testing

Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNSCLC
BeiGene 669
Not applicableNot Yet RecruitingNCT07620080
What this trial is testing

EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis

Who this might be right for
CholangiocarcinomaBiliary Stricture
David KARSENTI 120
Not applicableStudy completedNCT04189003
What this trial is testing

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

Who this might be right for
Oropharyngeal CancerHuman Papillomavirus-Related Carcinoma
Assistance Publique - Hôpitaux de Paris 66
Next Page